Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer

This study has been completed.
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: June 5, 2003
Last updated: November 5, 2013
Last verified: April 2004
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2011
  Estimated Primary Completion Date: No date given